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ABSTRACT
Phage integrases are required for recombination of
the phage genome with the host chromosome
either to establish or exit from the lysogenic state.
rC31 integrase is a member of the serine recombi-
nase family of site-specific recombinases. In the
absence of any accessory factors integrase is
unidirectional, catalysing the integration reaction
between the phage and host attachment sites,
attP attB to generate the hybrid sites, attL and
attR. The basis for this directionality is due to
selective synapsis of attP and attB sites. Here we
show that mutations in attB can block the integra-
tion reaction at different stages. Mutations at
positions distal to the crossover site inhibit recom-
bination by destabilizing the synapse with attP
without significantly affecting DNA-binding affinity.
These data are consistent with the proposal
that integrase adopts a specific conformation on
binding to attB that permits synapsis with attP.
Other attB mutants with changes close to the
crossover site are able to form a stable synapse
but cleavage of the substrates is prevented. These
mutants indicate that there is a post-synaptic
DNA recognition event that results in activation of
DNA cleavage.
INTRODUCTION
fC31 integrase and several of its relatives are being widely
used for precise engineering of complex genomes (1–8)
and are emerging as promising new tools for gene therapy
(9–15). In addition to being highly portable fC31
integrase is, unlike other recombinases used for genome
manipulation such as Cre and Flp, unidirectional
(7,16,17). In nature phage integrases are required for
recombination of the phage genome with the host
chromosome either to establish or exit from the lysogenic
state. For integration the host-encoded attB site
undergoes a conservative and reciprocal recombination
with the phage attP site to form the hybrid product sites,
attL and attR. During induction into the lytic cycle, the
phage genome excises and this reaction normally requires
integrase and an accessory protein Xis (18,19). Phage-
encoded integrases can belong to the tyrosine or the serine
recombinase families (20). Both families of proteins act
by binding to their cognate substrates and bringing
the DNAs together in a synapse. Recombination is
initiated by cleaving DNA strands, which undergo
strand exchange to form recombinant products and
these are then released (21). While the mechanism
of phage  integrase, a tyrosine recombinase, is well
understood (18,22,23), the mechanism of action of
integrases such as fC31 integrase that belong to the
serine recombinase family, is less clear.
All serine recombinases have a conserved catalytic
domain required for DNA cleavage and rejoining (20,24).
The resolvase/invertases also have a small ( 60 amino
acids; aa) C-terminal DNA-binding domain (25). The
serine integrases, some transposases and the staphylococ-
cal cassette recombinases (Ccr proteins; required for
the movement of methicillin resistance gene in MRSA)
are so-called large serine recombinases as they have
extensive C-terminal domains ( 300–500 aa in length; 20).
Sequence alignments of these large serine recombinases
indicate that they are an extremely diverse family.
Experiments with fC31 integrase, mycobacteriophage
Bxb1 integrase and TnpX transposase suggest that the
recombination mechanism used by the large serine
recombinases resembles that of the well-studied
resolvase/invertases (17,24,26–33). DNA cleavage occurs
at a 2bp crossover sequence to form a staggered break
and a transient covalent phosphoserine bond between the
recessed 50 ends and the recombinase is formed (17,27).
Strand exchange most likely occurs by rotation of two
recombinase subunits bound to half sites relative to the
other two subunits (34–37). Rejoining of the products is
dependent on the complementarity of the DNA sequence
at the staggered breaks; if there is a mismatch at this
sequence, joining of the products is severely inhibited but
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topology of the substrates (17,28,38).
Divergence from the resolvase paradigm by the serine
integrases occurs in the nature of substrate recognition
and the formation of the synapse. The pairs of recombina-
tion sites used by the serine integrases have diﬀerent
sequences; for example, the fC31 attP and attB sites share
39% sequence identity [Figure 1, (39)]. The recombination
sites are generally short,  50bp (10,17,29,40). The
minimal sites for fC31 integrase have been deﬁned as a
39bp attP site and a 34bp attB site (10). Under in vitro
conditions fC31 integrase converts  80% of attB and
attP to products in the absence of accessory proteins
and there are no restrictions on the topology of the
substrates (16,27,28). Moreover, in these in vitro reactions,
fC31 integrase is catalytically inert on all other combina-
tions of substrates including attL and attR (28). Hatfull
and colleagues have shown that Bxb1 integrase has similar
properties and they have gone on to show that Bxb1
integrase binds to its substrates as a dimer (17,26).
The synapse is therefore likely to contain a tetramer of
integrase subunits (26).
A major focus in our lab has been to understand why
fC31 integrase can only recombine attB and attP in vitro.
We have shown previously that integrase cannot synapse
pairs of recombination sites other than attP with attB
indicating that the formation of the synapse is the major
block to excision in vitro (27). We and others have
proposed that integrase adopts speciﬁc conformations
when bound to attP and attB sites that enable the
formation of a synapse, but when bound to attL and
attR disable or destabilize the synapse (26,27,29). In this
model, the interactions between integrase and attP and
attB are central to the formation of the synaptic interface.
Some clues as to the preferred sequences of attP and attB
have been obtained previously through studies that have
characterized the substrates used by integrase when one of
the cognate sites is not present (9,41,42). Pseudo-attB sites
in the bacterial host, Streptomyces coelicolor and other
actinomycetes show a strong preference for certain bases
[Figure 1, (41,43)]. Similarly, pseudo-attP sites have been
characterized in mammalian genomes and these also show
base speciﬁc preferences (Figure 1). Many of the bases
that are conserved in the pseudo-attP and pseudo-attB
sites are also conserved between attP and attB (Figure 1).
To examine the integrase–attB interaction in more
detail, the minimal attB site was subjected to mutagenesis
and the activities of the mutants assayed in recombination
and binding assays. Recombination defective attB
mutants that could still bind to integrase with aﬃnities
not dissimilar to the wild-type attB site were found to be
blocked either at synapsis or at DNA cleavage. The most
likely explanation is that there are two separate recogni-
tion events that occur between integrase and the attB site.
The ﬁrst event results in a protein–protein interface that
enables synapsis and the second post-synapsis event
results in activation of DNA cleavage.
MATERIALS AND METHODS
Bacterial strains andplasmids
Escherichia coli strains DH5 and DS941 were used
as general cloning hosts and were grown in LB or
2xYT (44). E. coli transformation, plasmid preparations
and DNA manipulation were performed as described
previously (44).
Plasmids pRT600 and pRT700 were constructed pre-
viously by insertion of annealed oligonucleotides RM1/
RM2 containing attB (51bp) and RM3/RM4 attP (50bp)
sites inserted into pGEM7 cut with EcoRI and Csp45I
(29). For this work, the attP site from pRT700 was excised
with BamHI and EcoRI and inserted into BamHI and
EcoRI cut pSP72 to form pRT702. Plasmids containing
mutant attB sites at all positions except for  /þ3,  /þ8
F
o
l
d
 
r
e
d
u
c
t
i
o
n
 
i
n
 
p
r
o
d
u
c
t
 
m
a
d
e
: :::    :: ::: : :: :   :   :
GGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTA
CCCAGCCTCCCGCACGGGAACCCGAGGGGCCCGCGCAT
CCCCAACTGGGGTAACCTTTGAGTTCTCTCAGTTGGGG
GGGGTTGACCCCATTGGAAACTCAAGAGAGTCAACCCC
attB
attP
0
5
10
15
20
25
30
35
GGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTA  attB
AAGGAGTCGGGGGTTACGTTGACGACTCCCATGACCGC 
GGAGGCCCGGGAGAAGCTTCTGCCTCTCCCGGGCCTCC 
GTGGTGCCCGGTGAGGCGTTCGGCACGCCGGGGTACCT 
pseB1
pseB2
pseB3
A
B
−
1
6
−
1
8
−
1
4
−
1
2
−
1
0
−
8
−
6
−
4
−
2
+
2
+
4
+
8
+
1
8
+
1
6
+
1
4
+
1
2
+
1
0
+
6
+
2
+
4
+
8
+
1
8
+
1
6
+
1
4
+
1
2
+
1
0
+
6
XO
Figure 1. fC31 attB and attP sites. (A) The double-stranded DNA
sequences of the S. coelicolor attB site (green) and the attP site (blue)
are shown. The crossover dinucleotides are shown in black. The colons
connecting the two sequences indicate the positions of sequence identity
between the aligned attB and attP sites. The grey shading indicates the
positions where sequence conservation can be detected between the attB
or attP sites and their pseudo-sites from Streptomyces or Mycobacteria
(pseudo-attB sites) or from human or mouse cell lines (pseudo-attP
sites) (9,41–43). (B) Summary of mutation scanning in attB. The attB
site is shown as a single-strand sequence where each base acts as point
on the x-axis of a histogram. The y-axis shows the fold reduction in
product made when mutations are introduced in attB. The positions are
annotated according to the numbering shown. The activities of attB
sites with double mutations at symmetrical positions (eg  /þ1,  /þ2,
etc.) are shown in pink and the activities of mutants with single
mutations are shown in black. The data for the summary graph were
calculated from the estimated absolute activities shown in Table 1,
Figure 2 and Supplementary Data, Figure S1. Beneath the attB
sequence, three of the S. coelicolor pseudo-attB sites [pseB1, pseB2 and
pseB3 (41)] are shown for comparison with the wild-type attB. The four
sites have been aligned and are shaded according to whether there is
100% identity (black background and white text) or 75% identity
(grey background) between the sites.
3408 Nucleic Acids Research, 2007, Vol. 35, No. 10and  /þ12 were constructed as for pRT600; annealed
oligonucleotides (see Supplementary Data, Table S1) were
inserted into pGEM7 cut with EcoRI and Csp45I.
Plasmids containing mutations at  /þ3,  /þ8 and
 /þ12 were constructed diﬀerently; PCR ampliﬁcation
using primers containing a randomized base at positions 3,
8 or 12 (Supplementary Data, Table S2) resulted in
fragments that could be inserted into pGEM7 and these
were then sequenced to determine the nature of the
mutations. To create the double mutants with mutations
at symmetrical positions, fragments containing the two
single mutations were spliced together using the unique
StyI site in the centre of the attB site. All the plasmids
containing the mutant attB sites were subjected to
conﬁrmation by sequencing.
Recombination assays
Standard recombination assays between two attachment
sites located on two separate plasmids were performed as
described previously. Plasmids (100ng each) containing
attB (or the mutant attBs) and attP were mixed with 18ml
of recombination buﬀer (10mM Tris pH 7.5, 1mM
EDTA pH 8, 100mM NaCl, 5mM DTT, 5mM spermi-
dine, 4.5% glycerol and 0.5mg/ml bovine serum albumin)
and fC31 integrase was added to the recombination
reaction to ﬁnal concentrations 0, 441, 110, 55, 27 or
14nM unless otherwise stated. Reactions were incubated
at 308C for 1h unless otherwise stated and terminated by
incubation at 658C for 10min. After addition of an
equal volume of 2  restriction buﬀer (20mM Tris-HCl
pH 7.9, 100mM NaCl, 20mM MgCl2,2 m M
DTT) the plasmids were treated with HindIII restriction
endonuclease (378C for 2h) and the fragments were
separated by electrophoresis through 0.8% agarose
gels in 1  TBE buﬀer (100V). HindIII linearizes the
substrates containing attB (or mutant attBs) and attP to
give DNA molecules of 3035 and 2491bp, respectively.
The recombination product is a cointegrate of the two
substrate plasmids and is cut by HindIII into two
fragments; 5435bp containing attL and 91bp containing
attR. Only the attL fragment is detected routinely
after electrophoresis.
Recombination reactions were also performed using
a plasmid encoding the attP site, pRT702, and annealed
oligonucleotides containing the attB sequence or its
mutant derivatives (the ‘oligo-plasmid’ assay; see
Table S2 in the Supplementary Data for the sequences
of the oligos) (17). pRT702 (100ng) was mixed with
4.5ng of annealed oligonucleotides encoding a mutant
attB site and 18ml of recombination buﬀer. fC31
integrase (1ml) was added to give ﬁnal concentrations as
described above (i.e. 0, 441, 110, 55, 27 and 14nM) and
the reactions were incubated at 308C for 1h. The
recombination reactions were terminated by heat inacti-
vating the samples at 658C for 10min and the products of
recombination were analysed on 0.8% agarose gels in 1 
TBE buﬀer (100V). The products of recombination were
identiﬁed as linear DNAs (2546bp).
DNA binding andradioactive recombination assays
DNA aﬃnity and synapse assays were performed as
described previously (29). DNA fragments for radioactive
labelling were prepared by digestion of pRT600
(encoding wt attB), pRT700 (encoding attP), or plasmids
containing cloned annealed oligonucleotide pairs encoding
mutant attB sites with HindIII and XhoI restriction
enzymes. The 72bp fragments containing the att sites
were separated on 4% agarose gel (Nusieve agarose) and
then puriﬁed using gel extraction columns (QIAGEN)
as per the manufacturer’s protocol. The concentration of
the puriﬁed fragment was determined on 4% agarose gels
following which the fragments were end-labelled using
DNA polymerase I large (Klenow) fragment in the
presence of [ 
32P]dCTP (as described previously in
Sambrook et al. (44)). Unless otherwise stated, binding
aﬃnity assays were performed with 1.0ng labelled probe
in binding buﬀer (20mM Tris-HCl pH 8.0, 0.1mM
EDTA, 50mM KCl, 5% glycerol), 1mg sonicated
salmon sperm DNA and integrase added to ﬁnal
concentrations of 0, 351, 87, 43, 21 and 10nM.
Reactions with no integrase contained 1mg BSA.
Reactions were incubated at 308C for 30min prior
to electrophoresis following which the reaction mix
were separated on 5% non denaturing 0.5  TBE
polyacrylamide gels in 0.5  TBE running buﬀer (200V,
5W for 2h).
For radioactive recombination assays, unlabelled
‘partner’ fragments prepared by PCR ampliﬁcation
of pRT600 and pRT700 with SP6 and T7 primers
containing either attP (193bp) or wt or mutant attBs
(194bp) were added to the radiolabelled attachment site
in the presence of integrase. Complexes containing
either the uncleaved synapse, the cleaved intermediates
with integrase bound covalently to the att sites,
and integrase bound to the labelled substrate and
products were observed by non-denaturing PAGE as
described previously (27). These assays were performed
using 1.5ng of labelled probe (72bp), 20ng of the
unlabelled fragment containing a ‘partner’ attachment
site and 66nM integrase in binding buﬀer.
Unless otherwise stated, all reactions were incubated
for a period of 2h at 308C prior to electrophoresis
on 5% non-denaturing polyacrylamide gels (200V, 5W
for 2h).
To detect the cleavage of the DNA fragments by
integrase, reactions were set up as for the radioactive
recombination assays but after incubation at 308C,
reactions were heat inactivated (728C for 10min)
then incubated with 1ml of subtilisin A (Sigma 0.1mg/ml
in 1  binding buﬀer) for 15min at 308C. Subtilisin was
inactivated (728C for 10min) and the reactions
were loaded onto a 0.5  TBE, 5% non-denaturing
polyacrylamide gel.
After electrophoresis gels were dried and exposed to a
phosphorimager screen (Fuji) for 16h and then
scanned (Fuji FLA3200 phosphorimager). Quantiﬁcation
of radioactivity was performed using the AIDA software
(Raytest, Straubenhardt, Germany).
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Wild-type fC31 and S12A integrase were puriﬁed as
described previously (27). Integrase concentration was
assayed using a method based on the dye-binding
procedure of Bradford (45) employing the BioRad
protein assay solution, and bovine serum albumin as a
standard.
RESULTS
Identification of defective mutationsin attB
The minimal attB site, according to Groth et al., (10) is
34bp with the crossover 50TT (abbreviated to XO) at the
centre (Figure 1). Footprinting conﬁrmed that integrase
binds either side of the crossover site in all the attachment
sites and, as integrase is a dimer in solution it probably
binds as a dimer (29). Moreover, we have shown that
integrase binds to attB and attP in a functionally
symmetrical manner. Thus in order to maximize any
phenotype arising from mutations in attB we generated a
set of doubly mutated sites with base pair changes at
symmetrical positions with respect to the crossover
sequence. To aid in the description of the positions of
mutations, the base pairs in the minimal attB and attP
sites were annotated with either a negative number when
they lie to the left of the crossover dinucleotide sequence
(50TT) i.e. B or P arm to use the  terminology) or positive
when it lies to the right of the crossover (B0 or P0 arm); the
numbers count upwards as the position extends away
from the crossover (Figure 1). Thus mutations in a double
mutant involving the two base pairs adjacent to the
crossover is at  /þ1 and mutations at the next position
moving outwards are at  /þ2, etc. Mutations were chosen
that would introduce sequence symmetry at the desired
position. Thus each double mutant was designed to
contain one of the four bases, A, T, C or G, at position
–x on the B arm and at þx on the B0 arm its complement,
T, A, G or C, respectively, was inserted. The choice of
mutation was made on the basis that the introduced bases
had to be diﬀerent from those present in both arms of attB
and preferably also diﬀerent to those seen in the pseudo-
attB sites (Figure 1). For example, position 15 is a T in the
B arm and a C in the B0 arm and the pseudo-attB sites
have a G in the B arm and a C or A in the B0 arm.
T-15C:Cþ15G and the T-15A:Cþ15T contain changes at
 /þ15 on the B and the B0 arm to base pairs that are
diﬀerent from both the wt and the pseudo-site sequences
and should be functionally the same mutation in both
arms. For most positions at least two mutant forms were
made but for some sites (positions 4, 7, 16) only one
option was available. Other positions where only a single
mutant form was made are at 14, 17 and 18.
Except for mutations at positions  /þ3,  /þ8 and
 /þ12 the activities of the double substituted attB
sites was ﬁrst assayed using annealed oligonucleotides.
Oligonucleotides containing the double substitutions were
puriﬁed by PAGE, annealed and used in an oligo-plasmid
recombination assay (17). In this assay, a supercoiled
plasmid containing attP was mixed with the
oligonucleotide containing attB or one of the mutant
forms and various concentrations of integrase. The extent
of linearization of the attP plasmid indicated the extent of
recombination and this was assayed after separation of the
DNA in an agarose gel. A control reaction using the wild-
type attB site was performed in every assay so that the
activities could be compared under identical conditions.
The lowest integrase concentration at which recombina-
tion could be observed was scored (Figure S1 and
Table 1).
Many of the mutant attB sites showed little or only
2-fold change in activity compared to the wild-type site.
These sites were changed at  /þ1,  /þ4,  /þ5,  /þ7,
 /þ10,  /þ11 and  /þ13 (Table 1, Figure 1).
The remaining mutants showed defective or partially
defective activity ranging from 4-fold less active than
wild type to apparently inactive. Oligos encoding sites
C-2G:Gþ2C, C-2A:Gþ2T, G-6A:Cþ6T, (G-6T:Cþ6A,
G-9T:Cþ9A, G-9A:C-9T, G-9C:C-9G, T-15C:Cþ15G,
G-16T:Gþ15A and G-18C:Aþ18G were cloned into
pGEM7 (Promega) so that the activities of the mutant
attB sites could be veriﬁed by a standard recombination
assay using both att sites residing on plasmids. Only one
of the mutant attB sites that was partially defective
(at position  /þ14) was not represented in the cloned
mutant attB site collection; this site was instead subjected
to single site substitutions (see later). T-15A:Cþ15T
was not cloned as a plasmid containing another mutant
at  /þ15 (T-15C:Cþ15G) with the same activity was
quickly obtained. A plasmid encoding G-6C:Cþ6G
was not obtained due to technical diﬃculties. Plasmids
containing mutations in C-3T:Gþ3A, C-3G:Gþ3C,
C-3A:Gþ3T, G-8T:Cþ8A, G-8C:Gþ8C, C-12A:Gþ12T
and C-12T:Gþ12A were obtained by PCR mutagenesis
as described in the Material and Methods section.
The relative activities of the double substitution mutants
were estimated compared to a standard reaction with wild-
type attB (Table 1 and Figures 1 and 2). As for the
oligo-plasmid assay the activity of each mutant site was
scored as the concentration of integrase required to
observe recombinants in an agarose gel stained with
ethidium bromide (Table 1). The relative activities
compared to the wild-type site are summarized graphically
(Figure 1).
Three of the mutant attB sites were very defective for
recombination and these contained substitutions at  /þ2,
 /þ15 and  /þ16. In all cases no recombination was
observed in either the oligo-plasmid or the standard assay
using these double substituted attB sites (Figure 2 and
Figure S1). Recombination was just detectable with attB
containing substituted  /þ18 in the plasmid assay with
351nM integrase (Figure 2). The low activity of the  /þ18
double mutant was surprising given that this position is
outside the minimal attB site deﬁned previously by Groth
et al. (10). The nature of the mutations made small
diﬀerences to activity in only a few mutants. The  /þ12
mutant containing the double transversion C-12A:Gþ12T
was only just active with 87nM integrase while the  /þ12
mutant containing the transitions C-12T:Gþ12A was
active with 43nM integrase (Figure 2). The G-6T:Cþ6A
transversions had similar activity to wild-type attB
3410 Nucleic Acids Research, 2007, Vol. 35, No. 10Table 1. List of mutant attB sites and their activity compared to the wild-type attB
Position of
mutation
Nature of
mutation
Sequence Activity of
integrase
a
  Wild type
\Oup\’,^articleacro,’\’,^articleacro,’-’,^volumeno,’(’,^volumeno,’)Printer\
^
xmlXPathEval: evaluation failed"
14nM
 /þ18 G-18C:Aþ18G 350nM
 /þ17 G-17T:Tþ17A 55nM
 /þ16 G-16T:Gþ16A 4441nM
 /þ15 T-15A:Cþ15T 4441nM
 /þ15 T-15C:Cþ15G 4441nM
 /þ14 G-14A:Gþ14T 110nM
 /þ13 C-13T:Cþ13A 27nM
 /þ13 C-13A:Cþ13T 27nM
 /þ12 C-12A:Gþ12T 350–87nM
 /þ12 C-12T:Gþ12A 43nM
 /þ11 A-11T:Gþ11A 14nM
 /þ11 A-11G:Gþ11C 14nM
 /þ10 G-10T:Gþ10A 14nM
 /þ10 G-10A:Gþ10T 14nM
 /þ9 G-9T:Cþ9A 55nM
 /þ9 G-9A:Cþ9T 55nM
 /þ9 G-9C:Cþ9G 55nM
 /þ8 G-8T:Cþ8A 55nM
 /þ8 G-8C:Cþ8G 55nM
 /þ7 C-7T:Cþ7A 27nM
 /þ6 G-6A:Cþ6T 55–27nM
 /þ6 G-6C:Cþ6G 110nM
 /þ6 G-6T:Cþ6A 14nM
 /þ5 T-5C:Tþ5G 14nM
 /þ5 T-5G:Tþ5C 27nM
 /þ4 G-4C:Cþ4G 14nM
 /þ3 C-3T:Gþ3A 27nM
 /þ3 C-3G:Gþ3C 27nM
 /þ3 C-3A:Gþ3T 55nM
 /þ2 C-2G:Gþ2C 4441nM
 /þ2 C-2A:Gþ2T 4441nM
 /þ1 C-1G:Gþ1C 14nM
 /þ1 C-1A:Gþ1T 14nM
 /þ1 C-1T:Gþ1A 14nM
 18 G-18C 27nM
 16 G-16T 4441nM
 15 T-15C 4441nM
 14 G-14A 27nM
 2 C-2G 14nM
þ18 Aþ18G 55nM
þ16 Gþ16A 27nM
þ15 Cþ15G 55nM
þ14 Gþ14T 14nM
þ2G þ2C 14nM
12 to 18 swap RL 4441nM
 12 to –182R 2R 4441nM
þ12 to þ18 2L 14nM
aConcentration of integrase required to observe recombinants in a 0.8% TBE gel stained with ethidium bromide. Two concentrations (350–87 or
55–27nM) are given when the level of recombination obtained at the lower concentration is much less than that obtained with 14nM integrase with
wild-type attB.
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(G-6A:Cþ6T) was 2-to 4-fold less active than attB
(Figure 2).
All of the mutant attB sites described in this section that
were cloned into plasmids were used to test whether they
would recombine with attL, attR or attB but no activity
was detected in any case. Thus none of these mutant sites
had any detectable gain-of-function.
The sequence on theleft side of attBhasagreater
role inattB function thanthe right side
The eﬀects of mutations at positions  /þ2,  /þ14,
 /þ15,  /þ16 and  /þ18 were studied further.
Oligonucleotides were synthesized that had single muta-
tions at either the  x position in the B arm or in the þx
position in the B0 arm. Recombination was performed
with the oligo-plasmid assay and with the standard
recombination assay using the sites cloned into pGEM7.
The attB sites containing the single mutations C-2G and
Gþ2C regained much of the activity of the wild-type attB
site suggesting that a correct interaction on one or other
side of the crossover at this position is suﬃcient for
recombination (Figure 2). Similarly the single mutation at
–18 or þ18 also regained some activity compared to
wild-type attB (Figure S1). Single mutations at the 15 and
16 positions behaved diﬀerently. Mutants at –15 or –16
had much greater eﬀects on recombination than the
mutants at þ15 or þ16. The single mutations Cþ15G and
Gþ16A regained some activity compared to the double
mutants T-15C:Cþ15G and G-16T:Gþ16A whereas the
single mutants at T-15C and G-16T did not (Figure 2).
A similar diﬀerence, but less so, was also observed at
position 14 where the left B arm was more sensitive to
mutation than the right B0 arm (Table 1). To test this
further we experimented with partially symmetrical sites.
The B arm of attB that included the region from –12 to
–18 was replaced with the þ12 to þ18 sequence from the
B0 side [2R ( 12 to  18)] and vice versa, [2L (þ12 to
þ18)]. The 2L (þ12 to þ18) attB site was as active as the
wild-type attB site whereas the 2R ( 12 to  18) site was
inactive (Figure 2). These data indicate that the sequence
in the left arm of attB plays a major role in attB function
and its loss removes all activity. A mutant attB site RL,
with the straight swap of the B arm sequence between  12
and  18 with the B0 arm sequence at þ12 to þ18
was inactive (Figure S1) indicating that whatever
positive role the  12 to  18 sequence plays in attB
function, it is not acting independently of other sequences
in the attB site.
Figure 2. Recombination activities of attB mutant sites. Recombination activities are shown for the wild-type attB site (A), mutant sites at position 2
(B), 6 (C), 12 (D), 15 (E), 16 (F)1 8( G). Panel H shows the activities of partially symmetrized attB sites that contain the right sequence between þ12
and þ18 changed to the same sequence as on the left ( 12 to  18), 2L (þ12 to þ18) or vice versa, 2R ( 12 to  18). Recombination assays were
performed using the standard plasmid assay containing the plasmid indicated in each panel and pRT702 encoding attP. The concentrations of
integrase used for each set of six reactions in panels A to C and E, F and H was 0, 441, 110, 55, 27 and 14nM. The concentrations of integrase used
for each set of six reactions in panels D and G was 0, 351, 87, 43, 21 and 10nM.
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forintegrase
This mutational analysis of attB showed that double
mutations at three positions  /þ2,  /þ15  /þ16 and the
single mutants at –15 and –16 were particularly defective
for recombination.
We have shown previously that it is possible to assay
several intermediate steps in recombination i.e. DNA
binding, formation of the synapse and cleavage of the
DNA to form the covalent intermediate in which integrase
is covalently bound to its cleaved substrate (27).
The mutant attB sites were used ﬁrst in aﬃnity assays
with integrase. As seen previously integrase bound to the
wild-type attB site with an aﬃnity of  60nM (27,29).
Most of the mutant attB sites bound with a similar aﬃnity
to the wild-type attB site including the severely recombi-
nation defective sites C-2A:Gþ2T and G-16T:Gþ16A
(Figure 3, Table 2). The mutant T-15C:Cþ15G had a
slightly lower aﬃnity for integrase ( 128nM) but this
loss of aﬃnity was abolished in the single mutant at
 15 (T-15C) which was still defective in recombination
(Table 2, Figures 1 and 2). Diﬀerences in binding
aﬃnities by integrase for mutant attB sites C-2A:Gþ2T,
G-16T:Gþ16A, T-15C and G-16T cannot therefore
account for the defectiveness of these sites in recombina-
tion. Mutations involving position 18 from the crossover
dinucleotide showed an  3-fold lower aﬃnity for inte-
grase than wild-type attB which could contribute to the
observed decrease in recombination activity (Figure 2).
It seems likely that attB sites with mutations at  /þ2,
 /þ15,  /þ16 were blocked elsewhere in the recombina-
tion pathway.
Cleavage by integrase of attBsiteswith mutationsat 2/12
isseverely inhibited
The formation of both the cleaved covalent intermediate
and the synapse can be observed in a recombination assay
using a radiolabelled attB or attP site, a cold partner att
site and integrase (27). These assays are performed in a
buﬀer that is sub-optimal for recombination (binding
buﬀer) that enriches for synaptic complexes and the
cleaved covalent complex compared with standard recom-
bination conditions (27). attP was labelled with [a 
32P]
dCTP, mixed with cold wild-type or mutant attB sites and
integrase and run in a non-denaturing PAGE gel
(Figure 4A, left panel). Compared to wild-type attB,
sites with  /þ2 changes (C-2G:Gþ2C and C-2A:Gþ2T)
showed an accumulation of synapse with almost unde-
tectable cleaved covalent complex or product formed
(Figure 4A, left panel). Treatment of the recombination
intermediates with the protease, subtilisin showed a small
amount of cleaved probe with C-2G:Gþ2C but this was
undetectable with C-2A:Gþ2T (Figure 4B). Subtilisin
treatment of reactions containing wild-type attB clearly
revealed the two recombination products attL and attR
but these were not visible with C-2A:Gþ2T and barely
visible with C-2G:Gþ2C (Figure 4B). As seen in the
recombination assay reverting one of the two mutations in
C-2G:Gþ2C back to the wild-type sequence was suﬃcient
to regain activity similar to the wild type attB site (C-2G
or Gþ2C in Figure 4A, left panel). The catalytically
inactive integrase mutant (S12A) was able to bind to
C-2G:Gþ2C, C-2A:Gþ2T, C-2G and Gþ2C normally to
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Figure 3. Binding aﬃnities by integrase for the wild-type and mutant
attB sites. Integrase was incubated with radiolabelled wild type (panel
A) and mutant attB sites (panels B–F). In each panel, the phosphor-
image shows the complexes obtained with increasing integrase
concentrations and, below, the quantitative analysis of the% bound
versus the concentration of integrase. Only the  /þ15 mutant
(T-15C:Cþ15G) and the  /þ18 mutant (G-18C:Aþ18G) sites showed
reduced binding aﬃnities for integrase under the conditions used.
A summary of the integrase concentrations required for 50% binding
of the diﬀerent attB mutants is shown in Table 2.
Table 2. Apparent binding aﬃnities by integrase for mutant attB sites
attB Site; position
of mutation
Nature of
mutation
Mean integrase
concentration for 50%
binding SD
a (nM)
Wt – 61.3 12.7
 /þ2 C-2A:Gþ2T 56.7 16.1
 2 C-2G 55.7 3.5
þ2G þ2C 58.3 6.7
 /þ15 T-15C:Cþ15G 127.7 24.2
 15 T-15C 68.3 5.8
þ15 Cþ15G 72.7 5.5
 /þ16 G-16T:Gþ16A 61.3 12.1
 16 G-16T 66.0 5.3
þ16 Gþ16A 53.3 6.1
 /þ18 G-18C:Aþ18G 189.7 30.7
 18 G-18C 194.7 17.1
þ18 Aþ18G 186.3 19.8
Partially symmetrical site 2L(þ12 - þ18) 61.7 5.7
aMeans and SDs were calculated from the integrase concentrations
required for 50% binding from three separate binding experiments.
Nucleic Acids Research, 2007, Vol. 35,No. 10 3413form a synaptic complex indistinguishable from the wild
type attB site (Figure 4A, right panel). Experiments in
which the labelled probes were attB or the  /þ2 mutant
derivatives and unlabelled attP was used to supershift the
complexes showed similar results, i.e. very little cleavage
of the  /þ2 mutant attB was observed (Supplementary
Data—Figure S2). These data indicate that attB sites with
a double substitution at  /þ 2 are able to generate a stable
synapse but are severely defective in cleavage of the
substrates.
The stability of thesynapse is reduced inattB sites
withmutationsat 2/115,2/116,215 and216
The attB sites with mutations at  /þ15 and  /þ16
that were defective in the standard recombination assay
did not appear to be defective in the radioactive assay to
detect intermediates (Figure 4A, left panel). The amounts
of cleaved covalent intermediate and shifted attL/attR
products were indistinguishable from the reaction with the
wild-type attB site (Figure 4A, left panel). The only
observable diﬀerence was in the amount of synapse, which
was reduced in the reactions with the most defective sites
i.e. T-15C:Cþ15G, T-15G, G-16T:Gþ16A and G-16T
and the appearance of some free product. These diﬀer-
ences were also observed when the attB sites were labelled
and incubated with integrase and cold attP
(Supplementary Data—Figure S2). When the S12A
catalytically inactive integrase mutant was used, there
was a small reduction in accumulation of the synaptic
complex with T-15C:Cþ15G, T-15G, G-16T:Gþ16A and
attB probe
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Figure 4. Synapse assays with wild-type and mutant attB sites. Panel (A) Radiolabelled attP was incubated with wild-type (left panel)
or the catalytically inactive integrase, S12A, (right panel) and a cold partner fragment containing wild-type attB (wt) or the indicated mutant
attB sites. The arrows show the positions of the synapse containing the radiolabelled substrate, the cold partner fragment and integrase
(Int:synapse attP/B), the covalently linked cleaved substrate (Int:cleaved attP/B), the shifted and free products (Int:attL/R and attL/R, respectively)
and the positions of the attP bound only to integrase (two complexes labelled Int:attP) or free (attP). Panel (B) The protease subtilisin was used to
reveal the extent of cleavage of attB sites and the products formed during the synapse assay. Arrows show the positions of the products, attL and
attR, the radiolabelled substrate and attB. The smear of radioactivity migrating faster than the free probe results from subtilisin treated cleaved
covalently linked complexes.
3414 Nucleic Acids Research, 2007, Vol. 35, No. 10G-16T compared with wild-type attB (Figure 4A,
right panel).
The inconsistency whereby mutants T-15C:Cþ15G and
G-16T:Gþ16A were inactive in the recombination assay
but active in the assay for intermediates was addressed.
As the standard recombination assay is performed over
1h and the synapse assay is over 2h, time courses were
performed for each assay. In the standard recombination
assay, products were observed in 2 and 3h with mutants
T-15C:Cþ15G and G-16T:Gþ16A (Figure 5A). Using
the more sensitive radioactive assay, cleaved substrates,
T-15C:Cþ15G and G-16T:Gþ16A, and their recombinant
products started to appear at 30min of incubation and
accumulated further over the next 30min whereas with the
wild-type attB, most of the substrate had been converted
to intermediates or products at 15min. Even after 60min,
less attP in the presence of T-15C:Cþ15G or
G-16T:Gþ16A was converted to product compared to
attP in the presence of wild-type attB (Figure 5B). Thus
both the mutants T-15C:Cþ15G and G-16T:Gþ16A
could undergo recombination but the reaction is con-
siderably slower than that for the wild-type attB site. As
there is a consistently reduced level of synaptic complex
observed with these mutant attB sites, it is likely that
changes in attB at  /þ15 and  /þ16 both result in an
unstable synapse that explains the slow rate of
recombination.
We reasoned that altered recombination conditions
might partially suppress the defect in T-15C:Cþ15G and
G-16T:Gþ16A by stabilizing the putative protein–protein
interface. Recombination was observed when the
NaCl concentration was increased to 500mM or 1M in
recombination buﬀer (Figure 6A). However, increasing
the concentration of NaCl did not increase the amount of
synaptic complex observed with these mutant attB sites
(Figure 6B). Indeed at 1M NaCl there was a reduction in
the level of synapse observed with the mutants at  /þ15
and  /þ16 and a slight reduction in the aﬃnity for the
attB site by integrase (Figure 6B and C).
DISCUSSION
The interactions between fC31 integrase and its attach-
ment sites are critical in determining the directionality of
recombination. In vitro integrase only recombines attB
and attP to form the hybrid products, attL and attR.
We have shown previously that, in vitro, integrase
selectively brings attP and attB together to form the
synapse and no other combination of sites forms a stable
synapse under these conditions (27). These observations
have led to the proposal that integrase adopts speciﬁc
conformations when bound to attP or attB that permit
formation of the protein:protein interface required for
stable synapsis (27,29). Here we showed that mutations in
attB can signiﬁcantly aﬀect the ability of integrase to
form a stable synapse or to cleave the substrates. These
perturbations in the reaction are likely to be due to
the absence of important interactions between integrase
and attB and could be indicative of ‘non-permissive’
conformations of integrase that block recombination at
these diﬀerent stages.
The mutations at  /þ2i nattB showed a failure to
cleave the DNA but these substrates could still form a
stable synapse (Figures 4–6). These data show clearly that
there is a post-synaptic activation step required for
recombination by fC31 integrase. This activation step
attB
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Figure 5. The rate of recombination with mutant attB sites
T-15C:Cþ15G and G-16T:Gþ16A is greatly reduced.
Panel (A) shows the appearance of products from recombination
assays using T-15C:Cþ15G and G-16T:Gþ16A as substrates after
prolonged incubation. Plasmids encoding the wild-type attB (wt) or the
indicated attB mutants were incubated with pRT702 (attP) for 1, 2 or
3h at 308C and then the products analysed by restriction and agarose
gel electrophoresis. After 2 and 3h some product (attL) is visible in the
lanes containing the  /þ15 and  /þ16 mutations. Panel (B) shows
the time-dependent appearance of recombination intermediates when
wild-type attB (wt) was used compared to C-2A:Gþ2T, T-15C:Cþ15G
or G-16T:Gþ16A. The  /þ2 mutant site rapidly forms a synapse
(Int:synapse attP/B) and thereafter the reaction is blocked. The  /þ15
and  /þ16 attB sites slowly accumulated the cleaved
intermediate (Int:cleaved attP/B) and some shifted product complexes
(Int:attL/R). The remaining complexes on the gel are as described
in Figure 4.
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Figure 6. High NaCl concentrations can partially suppress the recombination defective phenoytpe of the mutations. Panel (A) shows the appearance
of products from recombination assays using T-15C:Cþ15G, G-16T:Gþ16A, G-16T and T-15C as substrates after incubation in either 500mM or
1M NaCl. Plasmids encoding the wild-type attB (wt), or the above mutants were incubated with pRT702 (attP) in recombination buﬀer adjusted to
100mM, 500mM or 1M NaCl. After digesting with HindIII the DNA was separated in an agarose gel. The appearance of the 5435bp fragment
encoding attL is indicative of recombination. Panel (B) shows the synapse assays using the wild-type attB (wt), C-2A:Gþ2T, T-15C:Cþ15G and
G-16T:Gþ16A under diﬀerent NaCl conditions with wild type (left panel) or S12A integrase (right panel) with labelled attP. The complexes are
annotated as described in Figure 4.  /þ15 and  /þ16 mutant attB sites accumulated both the cleaved complex (Int:cleaved attP/B), the shifted
products (Int:attL/R) and released some free product (attL/R) with 500mM and 1M NaCl with the wild-type integrase. The synapse however as
indicated using the S12A integrase did not become more abundant in high NaCl buﬀer, if anything it reduced. Panel (C) shows that the binding
aﬃnity of attB sites for integrase in the presence of diﬀerent NaCl concentrations. Radiolabelled attB sites were incubated in binding buﬀer
containing 50mM, 500mM or 1M NaCl. Integrase was added at 66 nM. The shifted attB complexes are indicated by arrows. Only at 1M NaCl,
there was a slight increase in the free DNA for all four attB sites.
3416 Nucleic Acids Research, 2007, Vol. 35, No. 10depends on an interaction that has been disrupted in
the attB  /þ2 mutants, C-2G:Gþ2C or C-2A:Gþ2T.
The nature of the interaction is not known but could be a
speciﬁc base-pair contact or a DNA conformation that is
recognized. The block in DNA cleavage occurred in both
the mutant attB sites themselves and in the wild-type attP
sites (Figures 4–6 and Figure S2). This behaviour is
consistent with concerted DNA cleavage in the reaction
with wild-type recombination sites. Possibly the block in
cleavage in reactions containing the  /þ2 mutant sites
could be due to failure to undergo a conformational
change in the whole synaptic complex which would
normally lead to cleavage. Alternatively the DNA
conformation of the mutant sites prevents the catalytic
sites gaining access to the scissile phosphate. As reversion
of just one of the bases from the double mutant back to
the wild type was suﬃcient to regain most of the attB
activity it would seem that activation only requires a
‘correct’ interaction at one half-site of attB.
The mutants T-15C:Cþ15G and G-16T:Gþ16A were
able to recombine but at a slow rate compared to wild-
type attB (Figure 5). There was a consistent reduction in
the amount of synapse observed during recombination
with these mutants suggesting that the synaptic complex
was unstable (Figures 4 and 5). Raising the concentration
of NaCl partially suppressed the defect in recombination
with the  /þ15 and  /þ16 mutants but it is not clear
which step was aﬀected by NaCl (Figure 6). The stability
of the synapse did not increase in the presence of a higher
concentration of NaCl, if anything the binding aﬃnity
and the level of synapse was reduced at 1M NaCl
(Figure 6). Despite this, suppression was still observed
suggesting that high NaCl activates or stabilizes an event
later in the recombination pathway. The single point
mutants at –15 and –16 were suﬃcient to severely aﬀect
recombination while mutations at þ15 or þ16 had a lesser
eﬀect (Table 1, Figures 2, 4–6). Thus the single mutations
at positions –15 and –16 accounted for most of the defect
in the  /þ15 and  /þ16 double mutants. These data
argue that there could be a speciﬁc interaction between
the B arm and integrase that contributes signiﬁcantly
to the activity of the attB site. The partial symmetrization
of the attB sites (with either the sequence from the
B arm [2L (þ12 to þ18)] or with that from the B0 arm
[2R ( 12 to  18)]; Figure 2, panel H) showed that the
B arm was indeed more active than the B0 arm. However,
it is known from previous work that the attB and
attP sites act with integrase in a functionally symmetrical
manner as integrase does not control the relative
orientation of the sites when they come together at
synapsis (28). Thus the interactions by each subunit
of integrase bound to each arm of attB are not
independent of each other and we propose that a speciﬁc
integrase conformation that results from the –15,  16
interactions in the B arm is communicated through
both subunits.
These conclusions can be combined with information
from other large serine recombinases and the resolvases to
generate a model that focuses on substrate recognition
and formation of the synapse by integrase (adapted from
that published previously for Bxb1 integrase, 26;
Figure 7). In the resolvases, the DNA is contacted in the
attB mutants; 
−/+15, −/+16,
−15 or −16
attP
+2 −2
S S
S S
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+16
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attP
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attL
Blocked in −/+2  attB mutants 
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Activation of cleavage  Subunit rotation, religation of products, 
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Figure 7. Model for the mechanism of integrase. The integrase subunits are shown with a small N-terminal (catalytic) domain through which the
subunits may dimerize (26) and a large C-terminal domain that we propose recognizes the sequences in the outer ﬂanks of the recombination sites.
These recognition events, speciﬁcally  15 and  16 (annotated as blue bars) in attB, lead to an ‘induced ﬁt’ or stabilization of a speciﬁc conformation
of integrase that enables synapsis with integrase bound to attP. Diﬀerent conformations of integrase bound to either attB or attP are shown as
diﬀerent colours. The synaptic interface via the N-terminal catalytic domains is indicated based on the resolvase precedent; there is no evidence
to indicate that the C-terminal domains could also participate in a synaptic interface. Mutations at positions  15 or  16 (such as in T-15C:Cþ15G,
G-16T:Gþ16A), T-15C or G-16T do not induce the conformation of integrase that can form a stable synapse with attP so the rate of reaction
decreases (thin arrow). Mutations at  /þ2i nattB (red bars) are severely inhibited in cleavage but are capable of forming a stable synapse. These
mutants indicate that the formation of the synaptic complex is followed by a well-deﬁned activation step that results in concerted DNA cleavage.
After strand exchange integrase is bound to the hybrid sites and adopts a conformation that cannot synapse attL and attR. The putative tetrameric
complex rapidly dissociates to binary complexes containing integrase and either attL or attR. See text for more details.
Nucleic Acids Research, 2007, Vol. 35,No. 10 3417minor groove in the centre of each binding site and
through speciﬁc contacts in the major groove towards the
outer ﬂank of the site via the C-terminal DNA binding
domain (24,25). The geometry of DNA-binding is such
that the C-terminal domain of resolvase extends around
the DNA and contacts on the opposite side of the DNA to
the catalytic serine (25). As in Bxb1 and TnpX, fC31
integrase has a proteolytically sensitive site between the N
and C terminal domains (K152, unpublished
data)(26,30,46). Moreover, the C-terminal domains of
Bxb1 and TnpX have been shown previously to be capable
of binding speciﬁcally to DNA (26,30,46). Thus we
propose that the C-terminal domains interact with the
outer ﬂanks of the att sites, that these interactions
determine the conformations of integrase bound to each
site and therefore whether they are compatible for
synapsis. In attB this information is ‘read’ at least in
part from –15 and –16 where disruption of this interaction
disables the ability of integrase to form a stable synapse
(Figures 4–6). The model predicts that there is commu-
nication between the putative DNA-binding motifs in the
C-terminal domain and the regions of integrase that
generate the protein-protein interface for synapsis. We
currently envisage this communication as an allosteric
switch mediated by conformational changes. In gd resol-
vase, the synaptic interface is located at the DNA distal
surface of the catalytic domain and it is likely that the
serine integrases use the equivalent of this interface for
synapsis, although it is possible that the C-terminal
domain may also have a role in synapsis. After synapsis
an activation step is required for DNA cleavage and in
attB this depends on the base pairs at position  /þ2. In
attB only one of the  /þ2 bases needs to be wild type for
activity and this can be either on the B or B0 arm. Given
the proximity of  /þ2 to the scissile phosphate, position 2
is more likely to interact with the catalytic domain than
with the C-terminal domain. As in resolvase there may be
signiﬁcant conformation changes that occur with activa-
tion of recombination (34,37).
The data presented here provides a source of
information that could be used for the design of
alternative attB sites for genome engineering using
fC31 integrase. Indeed we have already used this
information to create a non-methylatable attB site for
use in vertebrate cell lines (4). In this site, attB
m, the CpG
steps have been replaced with bases that we have shown
here were neutral with respect to recombination activity.
It is noteworthy that the positions in attB that are critical
for recombination other than position 2 i.e. positions 15,
16 were not highlighted as being particularly preferred
in the pseudo-attB sites (Figure 1). However all of the
pseudo-attB sequences have either the wild-type C at  2
or a wild-type G at þ2 (Figure 1) (41,43). It is also
noticeable that the regions where there are most identities
between attB and attP are not particularly sensitive to
mutation (Figure 1). A plausible explanation for both
these observations is that the 24bp of att site DNA from
about position 11 to the crossover site is a core sequence
that integrase binds to speciﬁcally. We propose that the
role of positions 15 and 16 in attB revealed by this study is
to greatly enhance the eﬃciency of the reaction and
eﬀectively discriminate between the pseudo-sites and the
cognate attB site. It is envisaged that this data and a
similar analysis with attP will enable an understanding of
the optimal sequences to target for continued application
of fC31 integrase.
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